Blog Home
DrugPatentWatch Home
Plans & Pricing
About
Contact

Cart
Checkout
Checkout
Comprehensive Drug Patent Profiles
Decision-Making for Generic Drug Entry and Branded Drug Lifecycle Management
Drug Patent News
DrugPatentWatch Insights Submission Form
DrugPatentWatch Report Store
DrugPatentWatch Report Store
DrugPatentWatch Reports Terms & Conditions
Excipient Business Development Profiles
My account
Courses
Checkout
Order Received
Order Failed
Terms & Conditions
Account

Drug Patent Expirations for the Week of April 18, 2021

By / April 18, 2021

ZYDELIG (idelalisib)

Gilead sciences incPatent: 6,800,620Expiration: Apr 24, 2021

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Post navigation

Which pharmaceutical companies have the most powder dosed drugs?

Pharmaceutical companies with the most ‘New Patient Population’ drugs

New patent expiration for Arbor Pharms drug BIDIL

Patent Expiration / By

Patent delisted for Teva Pharms drug COPAXONE

Patent Expiration / By

Get Email Updates

Make Better Decisions

See Plans and Pricing

Drug Patent Reports

Shop now

Search for:

Make Better Decisions with DrugPatentWatch

Related Posts